Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Capturing Readmission Internationally to Prevent Readmission by Safer@Home

NCT02621723 is registered in ClinicalTrials.gov with Amsterdam UMC, location VUmc as lead sponsor.

NCT NCT02621723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02621723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Capturing Readmission Internationally to Prevent Readmission by Safer@Home
Lead sponsor
Amsterdam UMC, location VUmc
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2016
Completion date
January 31, 2018
Enrollment
1,000 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

hospital readmission